<DOC>
<DOCNO>EP-0647628</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Acridinium derivatives and their use in luminescence immunoassays
</INVENTION-TITLE>
<CLASSIFICATIONS>C07D40112	G01N3358	C07D40100	C07D21900	G01N33533	C07D21904	G01N3358	G01N33533	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>C07D	G01N	C07D	C07D	G01N	C07D	G01N	G01N	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>C07D401	G01N33	C07D401	C07D219	G01N33	C07D219	G01N33	G01N33	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The invention relates to novel acridinium derivatives of the formula I: 
<
IMAGE
>
 in which R
<
1
>
 is hydrogen, an alkyl, alkenyl or alkynyl radical having 1 to 10 carbon atoms, a benzyl or aryl group, R
<
2
>
 and R
<
3
>
 are hydrogen, an alkyl group having 1 to 4 carbon atoms, a substituted or unsubstituted amino group, a carboxyl, C1-C4-alkoxy, cyano or nitro group or halogen, R
<
4
>
 is a radical in which a sulphonamide group is bonded directly to the carbonyl group via the nitrogen and A
<
(-)
>
 is an anion which does not interfere with the chemiluminescence; and their use in luminescence immunoassays.
</ABSTRACT>
<APPLICANTS>
</APPLICANTS>
<INVENTORS>
</INVENTORS>
<CLAIMS>
A luminescent compound which comprises an
acridinium derivative of the formula I



in which

R
1
 is hydrogen, an alkyl, alkenyl or alkynyl
radical with 1 to 10 carbon atoms or a benzyl,

phenyl or naphthyl group,
R
2
 and R
3
 are hydrogen, an alkyl group with 1 to 4
carbon atoms, an amino group or a mono- or di-C
1
-C
4

alkylamino group, where the alkyl radicals can be
monosubstituted by hydroxyl, and morpholine, a

carboxyl, C
1
-C
4
-alkoxy, cyano or nitro group or
halogen,
R
4
 is a radical in which a substituted sulfonamide
group is bonded via the nitrogen directly to the

carbonyl group, and
A
-
 is an anion which does not impair the
chemiluminescence,
 
excluding acridinium compounds of the formula I in

which R
1
, R
2
 and R
3
 are each as defined above and
R
4
 is a substituted sulfonamide group of the
formula V or VI



where

X
is a branched or unbranched C
1
-C
5
-alkylene group
or is a phenylene or naphthylene group or is

quinole, indole, pyrrole or pyridine,
R
5
is a reactive group which under mild conditions
is capable of bonding selectively with amino,

carboxyl, thiol or other functional groups in
substances of biological interest, and
R
6
in the formula V is an alkyl or alkenyl radical
having 1 to 10 carbon atoms, a C
1
-C
4
-alkyl-mono-substituted
or -disubstituted amino group or is

a morpholino, benzyl, phenyl or naphthyl group
which is optionally substituted by hydroxyl,

amino, alkoxy of 1 to 4 carbon atoms or phenoxy
or naphthoxy groups, and
R
6
in the formula VI, as well as the substituents
mentioned, may additionally be hydrogen,

where the acridinium derivative of the formula I is
bonded directly or via a bridge molecule to a

protein, a polypeptide or another substance of
biological interest to form a stable

immunologically active conjugate.
A compound as claimed in claim 1, wherein the
substance of biological interest is selected from

the group consisting of antigens, hormones,
steroids, drugs, drug metabolites, toxins,

alkaloids and antibodies. 
A luminescence immunoassay for the determination of
an antigenic substance in a liquid sample, in

which, in a competitive process or a sandwich
process, at least one immunologically active

component is immobilized on a solid phase and at
least one other component, the tracer, is a

luminescent compound as claimed in claim 1.
A luminescence immunoassay as claimed in claim 3,
which comprises


a) incubating an immobilized antibody, which reacts
specifically with an antigen, with a sample of

the liquid under investigation and a conjugate
of the antigen and a chemiluminescent acridinium

derivative of the formula I as claimed in claim
1;
b) separating off the sample and the unbound
labeled conjugate;
c) bringing the bound labeled conjugate together
with an oxidizing agent in order to cause photoemission

and
d) determining the amount of antigen present from
the photoemission intensity measured.
A luminescence immunoassay as claimed in claim 4,
wherein the liquid under investigation is separated

off from the immobilized antibody before addition
of the labeled conjugate.
A luminescence immunoassay as claimed in claim 3,
which comprises


a) incubating an immobilized antibody, which reacts
specifically with an antigen, with a sample of

the liquid under investigation and a conjugate
of a second, specifically reacting antibody and

a chemiluminescent acridinium derivative of the
formula I as claimed in claim 1; 
b) separating off the sample and the unbound
labeled conjugate;
c) bringing the bound labeled conjugate together
with an oxidizing agent in order to cause photoemission

and
d) determining the amount of antigen present from
the photoemission intensity measured.
A luminescence immunoassay as claimed in claim 6,
wherein the liquid under investigation is separated

off from the immobilized antibody before addition
of the labeled conjugate.
A luminescence immunoassay as claimed in claim 3,
which comprises


a) incubating an immobilized antigen, which reacts
specifically with an antibody, with a sample of

the liquid under investigation and a solution of
the conjugate of the antibody and a chemiluminescent

acridinium derivative of the formula I
as claimed in claim 1;
b) separating off the sample and the unbound
labeled conjugate;
c) bringing the bound labeled conjugate together
with an oxidizing agent in order to cause photoemission

and
d) determining the amount of antigen present from
the photoemission intensity measured.
A luminescence immunoassay as claimed in claim 3,
which comprises


a) incubating an immobilized antigen which reacts
specifically with an antibody, with a solution

of the conjugate of the antibody and a
chemiluminescent acridinium derivative of the

formula I as claimed in claim 1;
b) separating off the unreacted labeled conjugate;
c) adding a sample of the liquid under investigation; 
d) subsequently separating off the sample again;
e) bringing the bound labeled conjugate together
with an oxidizing agent in order to cause photoemission

and
f) determining the amount of antigen present from
the photoemission intensity measured.
A luminescence immunoassay as claimed in claim 3,
which comprises


a) incubating an immobilized antigen, which reacts
specifically with the antibody, with a solution

of the conjugate of the antibody and a
chemiluminescent acridinium derivative of the

formula I as claimed in claim 1;
b) adding a sample of the liquid under investigation;
c) bringing the bound labeled conjugate together
with an oxidizing agent in order to cause photoemission

and
d) determining the amount of antigen present from
the photoemission intensity measured.
</CLAIMS>
</TEXT>
</DOC>
